Pistachio power: daily nuts may boost energy and fullness for GLP-1 users

NCT ID NCT07244445

First seen Nov 26, 2025

Summary

This study tests whether eating 2 ounces of pistachios daily for 12 weeks helps people on GLP-1 medications (like semaglutide or tirzepatide) feel fuller, have more energy, and improve their diet quality. Researchers will track satiety, fatigue, mood, and body composition in 108 adults who have been on these drugs for at least three months. The goal is to see if a simple dietary addition can enhance nutrition and well-being during weight management.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY/OVERWEIGHT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospitals Cleveland Medical Center

    RECRUITING

    Clevland, Ohio, 44106, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

pistachios

What this could lead to

If it works, this could show that adding pistachios to your diet while on GLP-1 medications helps with fullness, energy, and overall nutrition.

What could go wrong

This is a small, early-stage study (108 people) looking at feelings and diet quality, not hard outcomes like weight loss. Results may not apply to everyone.

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.